Pulse Biosciences (PLSE) Asset Utilization Ratio (2022 - 2026)

Pulse Biosciences (PLSE) posted quarterly Asset Utilization Ratio of 0.0 for Q3 2025, down 79.01% quarter-over-quarter from 0.0 in Q1 2023.

Pulse Biosciences (PLSE) Asset Utilization Ratio (2022 - 2026) Analysis & Trends

Pulse Biosciences' Asset Utilization Ratio history runs 3 years deep, the most recent figure standing at 0.0 for Q3 2025.

In Q3 2025, Asset Utilization Ratio changed N/A year-over-year to 0.0; the TTM figure through Sep 2025 stood at 0.0 (changed N/A YoY), while the FY2022 annual figure was 0.01, down 63.35% from the prior year.
Asset Utilization Ratio for Q3 2025 stood at 0.0, down from 0.0 in the prior quarter.
The five-year high for Asset Utilization Ratio was 0.05 in Q2 2022, with the low at 0.0 in Q3 2025.
The 3-year median for Asset Utilization Ratio is 0.01 (2022), against an average of 0.02.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Asset Util. (Qtr)
1	Intuitive Surgical	132.71 Bn	127.50 Bn	1.96 Bn	0.54
2	Becton Dickinson	51.57 Bn	50.71 Bn	2.32 Bn	0.46
3	Alcon	35.52 Bn	34.17 Bn	1.68 Bn	0.34
4	Resmed	33.28 Bn	31.81 Bn	861.22 Mn	0.64
5	Medline	27.86 Bn	25.18 Bn	2.22 Bn	0.73
6	West Pharmaceutical Services	25.15 Bn	24.71 Bn	329.20 Mn	0.81
7	Solventum	15.31 Bn	14.91 Bn	1.29 Bn	0.59
8	Cooper Companies	14.86 Bn	14.72 Bn	735.40 Mn	0.34
9	Baxter International	13.63 Bn	11.48 Bn	1.03 Bn	0.56
10	Pulse Biosciences	3.33 Bn	3.33 Bn	161,000.00	0.01

Download Data